Compare HYI & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HYI | SEER |
|---|---|---|
| Founded | 2010 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 135.2M | 113.0M |
| IPO Year | 2010 | 2020 |
| Metric | HYI | SEER |
|---|---|---|
| Price | $9.24 | $1.35 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 96.8K | ★ 157.6K |
| Earning Date | 01-01-0001 | 11-10-2026 |
| Dividend Yield | ★ 9.59% | N/A |
| EPS Growth | N/A | ★ 9.40 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $16,578,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $20.50 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 16.99 |
| 52 Week Low | $9.42 | $1.36 |
| 52 Week High | $11.26 | $2.38 |
| Indicator | HYI | SEER |
|---|---|---|
| Relative Strength Index (RSI) | 28.03 | 19.60 |
| Support Level | N/A | N/A |
| Resistance Level | $10.66 | $1.81 |
| Average True Range (ATR) | 0.14 | 0.11 |
| MACD | -0.03 | -0.02 |
| Stochastic Oscillator | 5.69 | 4.44 |
Western Asset High Yield Defined Opps. is a non-diversified, limited-term, closed-end management investment company. The company's investment objective is to provide high income and seek capital appreciation. The fund invests a majority of its net assets in a portfolio of high-yield corporate fixed-income securities issued or originated by U.S. or foreign public or private corporations and other business entities, with varying maturities.
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.